Go Pro
→ Gold Explorer Sits Between Barrick’s Nevada Giants (From Wall Street Logic) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$89.69
-0.5%		$80.47
$54.11
▼
$92.59
$34.02B1.424.50 million shs1.92 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$70.56
+0.2%		$68.02
$58.75
▼
$89.77
$31.81B0.72.66 million shs2.07 million shs
Insulet Corporation stock logo
PODD
Insulet
$148.14
-0.2%		$154.73
$126.40
▼
$354.88
$10.29B1.082.04 million shs1.11 million shs
ResMed Inc. stock logo
RMD
ResMed
$231.03
-0.1%		$214.34
$180.26
▼
$284.87
$33.37B0.771.56 million shs1.16 million shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-1.01%+1.10%+8.02%+23.87%+19.64%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
-1.14%-4.72%+3.53%+13.53%-4.49%
Insulet Corporation stock logo
PODD
Insulet
-0.19%+3.73%-10.26%+3.55%-56.34%
ResMed Inc. stock logo
RMD
ResMed
-3.50%-2.01%+9.57%+24.11%-15.71%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
DexCom, Inc. stock logo
DXCM
DexCom
$89.69
-0.5%		$80.47
$54.11
▼
$92.59
$34.02B1.424.50 million shs1.92 million shs
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$70.56
+0.2%		$68.02
$58.75
▼
$89.77
$31.81B0.72.66 million shs2.07 million shs
Insulet Corporation stock logo
PODD
Insulet
$148.14
-0.2%		$154.73
$126.40
▼
$354.88
$10.29B1.082.04 million shs1.11 million shs
ResMed Inc. stock logo
RMD
ResMed
$231.03
-0.1%		$214.34
$180.26
▼
$284.87
$33.37B0.771.56 million shs1.16 million shs
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
DexCom, Inc. stock logo
DXCM
DexCom
-1.01%+1.10%+8.02%+23.87%+19.64%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
-1.14%-4.72%+3.53%+13.53%-4.49%
Insulet Corporation stock logo
PODD
Insulet
-0.19%+3.73%-10.26%+3.55%-56.34%
ResMed Inc. stock logo
RMD
ResMed
-3.50%-2.01%+9.57%+24.11%-15.71%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
DexCom, Inc. stock logo
DXCM
DexCom
2.89
Moderate Buy$88.71-1.09% Downside
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
2.48
Hold$77.7310.16% Upside
Insulet Corporation stock logo
PODD
Insulet
2.44
Hold$195.4031.90% Upside
ResMed Inc. stock logo
RMD
ResMed
2.38
Hold$240.314.02% Upside

Current Analyst Ratings Breakdown

Latest PODD, RMD, DXCM, and GEHC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/31/2026
ResMed Inc. stock logo
RMD
ResMed
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOverweight$255.00 ➝ $267.00
8/19/2026
ResMed Inc. stock logo
RMD
ResMed
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$230.00
8/19/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
BTIG Research logo
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$79.00
8/19/2026
ResMed Inc. stock logo
RMD
ResMed
Rothschild & Co Redburn logo
Rothschild & Co Redburn
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$230.00
8/12/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
8/11/2026
DexCom, Inc. stock logo
DXCM
DexCom
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/11/2026
ResMed Inc. stock logo
RMD
ResMed
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/11/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell ➝ Hold
8/7/2026
ResMed Inc. stock logo
RMD
ResMed
Robert W. Baird logo
Robert W. Baird
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$213.00
8/7/2026
ResMed Inc. stock logo
RMD
ResMed
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetOverweight$260.00 ➝ $255.00
8/7/2026
ResMed Inc. stock logo
RMD
ResMed
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetSector Perform$234.00 ➝ $244.00
(Data available from 9/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
DexCom, Inc. stock logo
DXCM
DexCom
$4.66B7.26$2.75 per share32.56$6.95 per share12.91
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$20.63B1.55$5.89 per share11.98$24.33 per share2.90
Insulet Corporation stock logo
PODD
Insulet
$2.71B3.79$6.31 per share23.47$20.51 per share7.22
ResMed Inc. stock logo
RMD
ResMed
$5.65B5.89$12.91 per share17.89$45.65 per share5.06
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
DexCom, Inc. stock logo
DXCM
DexCom
$836.30M$2.5335.4529.121.5120.12%35.94%14.75%10/29/2026 (Estimated)
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$2.08B$4.3615.2113.041.869.33%20.12%5.74%11/4/2026 (Estimated)
Insulet Corporation stock logo
PODD
Insulet
$247.10M$5.3527.6919.241.1712.29%29.29%13.31%11/5/2026 (Estimated)
ResMed Inc. stock logo
RMD
ResMed
$1.52B$10.4322.1517.641.4526.94%25.58%18.89%10/29/2026 (Estimated)

Latest PODD, RMD, DXCM, and GEHC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q4 2026
ResMed Inc. stock logo
RMD
ResMed
$2.89$2.95+$0.06$2.64$1.46 billion$1.46 billion
8/5/2026Q2 2026
Insulet Corporation stock logo
PODD
Insulet
$1.47$1.66+$0.19$1.37$787.39 million$801.70 million
7/30/2026Q2 2026
DexCom, Inc. stock logo
DXCM
DexCom
$0.6110$0.70+$0.0890$0.64$1.29 billion$1.31 billion
7/29/2026Q2 2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$1.04$1.13+$0.09$1.24$5.26 billion$5.30 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
DexCom, Inc. stock logo
DXCM
DexCom
N/AN/AN/AN/AN/A
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
$0.140.20%N/A3.21%1 Years
Insulet Corporation stock logo
PODD
Insulet
N/AN/AN/AN/AN/A
ResMed Inc. stock logo
RMD
ResMed
$2.641.14%+9.00%25.31%13 Years

Latest PODD, RMD, DXCM, and GEHC Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/6/2026
ResMed Inc. stock logo
RMD
ResMed
quarterly$0.661.15%8/20/20268/20/20269/24/2026
6/30/2026
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
quarterly$0.03500.23%7/24/20267/24/20268/14/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
DexCom, Inc. stock logo
DXCM
DexCom
0.47
1.73
1.43
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.92
1.26
0.97
Insulet Corporation stock logo
PODD
Insulet
0.65
2.48
1.83
ResMed Inc. stock logo
RMD
ResMed
0.06
3.10
2.42

Institutional Ownership

CompanyInstitutional Ownership
DexCom, Inc. stock logo
DXCM
DexCom
97.75%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
82.06%
Insulet Corporation stock logo
PODD
Insulet
N/A
ResMed Inc. stock logo
RMD
ResMed
54.98%

Insider Ownership

CompanyInsider Ownership
DexCom, Inc. stock logo
DXCM
DexCom
0.28%
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
0.36%
Insulet Corporation stock logo
PODD
Insulet
0.36%
ResMed Inc. stock logo
RMD
ResMed
0.65%
CompanyEmployeesShares OutstandingFree FloatOptionable
DexCom, Inc. stock logo
DXCM
DexCom
11,000377.36 million376.30 millionOptionable
GE HealthCare Technologies Inc. stock logo
GEHC
GE HealthCare Technologies
54,000451.69 million450.06 millionOptionable
Insulet Corporation stock logo
PODD
Insulet
5,40069.35 million69.10 millionOptionable
ResMed Inc. stock logo
RMD
ResMed
11,370144.25 million143.31 millionOptionable

Recent News About These Companies

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 9,064 Shares of ResMed Inc. $RMD
September 2 at 5:04 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-ubs-am-a-distinct-business-unit-of-ubs-asset-management-americas-llc-purchases-9064-shares-of-resmed-inc-rmd-2026-09-02/
ResMed Inc. $RMD Shares Sold by Van ECK Associates Corp
September 2 at 4:57 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-resmed-inc-rmd-shares-sold-by-van-eck-associates-corp-2026-09-02/
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ResMed Inc. - RMD
September 1 at 6:25 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/01/3354743/1087/en/investor-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-resmed-inc-rmd.html
ResMed Launches $450 Million Accelerated Share Repurchase
September 1 at 5:31 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/resmed-launches-450-million-accelerated-share-repurchase?utm_source=marketbeat.com&utm_medium=referral
ResMed Inc. $RMD Stock Position Raised by Railway Pension Investments Ltd
September 1 at 6:01 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-resmed-inc-rmd-stock-position-raised-by-railway-pension-investments-ltd-2026-09-01/
Quantitative Investment Management LLC Invests $2.21 Million in ResMed Inc. $RMD
September 1 at 5:51 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-quantitative-investment-management-llc-invests-221-million-in-resmed-inc-rmd-2026-09-01/
Public Employees Retirement System of Ohio Takes $9.75 Million Position in ResMed Inc. $RMD
September 1 at 5:03 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-public-employees-retirement-system-of-ohio-takes-975-million-position-in-resmed-inc-rmd-2026-09-01/
ResMed Inc. (NYSE:RMD) Receives Consensus Rating of "Hold" from Analysts
September 1 at 2:36 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30995604
ResMed Inc. (NYSE:RMD) Given Average Rating of "Hold" by Brokerages
September 1 at 2:28 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/consensus-resmed-inc-nyse-rmd-given-average-rating-of-hold-by-brokerages-2026-09-01/
Rakuten Investment Management Inc. Takes Position in ResMed Inc. $RMD
August 31 at 5:19 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-rakuten-investment-management-inc-takes-position-in-resmed-inc-rmd-2026-08-31/
GTS Securities LLC Has $2.05 Million Holdings in ResMed Inc. $RMD
August 30 at 6:39 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-gts-securities-llc-has-205-million-holdings-in-resmed-inc-rmd-2026-08-30/
United Capital Financial Advisors LLC Purchases New Holdings in ResMed Inc. $RMD
August 30 at 5:22 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-united-capital-financial-advisors-llc-purchases-new-holdings-in-resmed-inc-rmd-2026-08-30/
Freestone Grove Partners LP Invests $1.52 Million in ResMed Inc. $RMD
August 30 at 3:44 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-freestone-grove-partners-lp-invests-152-million-in-resmed-inc-rmd-2026-08-30/
Canada Pension Plan Investment Board Buys New Position in ResMed Inc. $RMD
August 30 at 3:43 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-canada-pension-plan-investment-board-buys-new-position-in-resmed-inc-rmd-2026-08-30/
The Manufacturers Life Insurance Company Makes New Investment in ResMed Inc. $RMD
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-the-manufacturers-life-insurance-company-makes-new-investment-in-resmed-inc-rmd-2026-08-29/
Empowered Funds LLC Buys New Shares in ResMed Inc. $RMD
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-empowered-funds-llc-buys-new-shares-in-resmed-inc-rmd-2026-08-29/
Corient Private Wealth LP Purchases Shares of 85,266 ResMed Inc. $RMD
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-corient-private-wealth-lp-purchases-shares-of-85266-resmed-inc-rmd-2026-08-29/
North Star Asset Management Inc. Takes Position in ResMed Inc. $RMD
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-north-star-asset-management-inc-takes-position-in-resmed-inc-rmd-2026-08-28/
103,833 Shares in ResMed Inc. $RMD Purchased by Jefferies Financial Group Inc.
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-103833-shares-in-resmed-inc-rmd-purchased-by-jefferies-financial-group-inc-2026-08-28/
MASTERINVEST Kapitalanlage GmbH Takes $3.77 Million Position in ResMed Inc. $RMD
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-masterinvest-kapitalanlage-gmbh-takes-377-million-position-in-resmed-inc-rmd-2026-08-28/
Caisse de depot et placement du Quebec Acquires Shares of 409,697 ResMed Inc. $RMD
August 28, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-caisse-de-depot-et-placement-du-quebec-acquires-shares-of-409697-resmed-inc-rmd-2026-08-28/

New MarketBeat Followers Over Time

Media Sentiment Over Time

DexCom stock logo

DexCom NASDAQ:DXCM

$89.69 -0.45 (-0.50%)
Closing price 04:00 PM Eastern
Extended Trading
$89.91 +0.22 (+0.25%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; and Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions. It has also submitted FDA review for Dexcom Stelo for people with type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

GE HealthCare Technologies stock logo

GE HealthCare Technologies NASDAQ:GEHC

$70.56 +0.14 (+0.20%)
Closing price 04:00 PM Eastern
Extended Trading
$71.06 +0.50 (+0.72%)
As of 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Insulet stock logo

Insulet NASDAQ:PODD

$148.14 -0.24 (-0.16%)
Closing price 04:00 PM Eastern
Extended Trading
$147.50 -0.64 (-0.43%)
As of 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. The company's Omnipod platform includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5) which includes a proprietary AID algorithm embedded in the Pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless bluetooth communication; Omnipod DASH that features a bluetooth enabled Pod that is controlled by a smartphone-like Personal Diabetes Manager with a color touch screen user interface; and Omnipod GO, a standalone, wearable, insulin delivery system that provides a fixed rate of continuous rapid-acting insulin for 72 hours. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, Australia, and internationally. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

ResMed stock logo

ResMed NYSE:RMD

$231.03 -0.33 (-0.14%)
Closing price 03:59 PM Eastern
Extended Trading
$230.82 -0.21 (-0.09%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas